Search Jim Cramer's "Mad Money" trading recommendations using our exclusive "Mad Money" Stock Screener.
NEW YORK (TheStreet) -- Here are some of the hot stocks Jim Cramer talked about on Thursday's Mad Money on CNBC:
Receptos (RCPT) : Cramer said Receptos is one of the most exciting speculative biotech companies he's ever seen. TheStreet's bio-tech reporter Adam Feuerstein has a detailed look at Receptos' multiple sclerosis treatment ozanimod, which he calls superior to Novartis' (NVS - Get Report) Gilenya, a drug that generates $2.6 billion-a-year in sales.
To read a full recap of "Mad Money" on CNBC, click here.
To watch replays of Cramer's video segments, visit the Mad Money page on CNBC.
To sign up for Jim Cramer's free Booyah! newsletter with all of his latest articles and videos please click here.
-- Written by Scott Rutt in Washington, D.C.
To email Scott about this article, click here: Scott RuttFollow Scott on Twitter @ScottRutt or get updates on Facebook, ScottRuttDC